跳至主要内容
临床试验/NCT07695285
NCT07695285尚未招募2 期

Lemborexant Use for Cognition Improvement in Postoperative Delirium in Elderly Patients: A Randomized Controlled Trial

Beijing Tiantan Hospital0 个研究点目标入组 992 人开始时间: 2026年9月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
尚未招募
发起方
入组人数
992
主要终点
The incidence of POD

研究概览

简要总结

This prospective, randomized controlled trial aims to investigate the perioperative use of lemborexant, an orexin receptor antagonist, for reducing postoperative delirium (POD) in elderly patients undergoing general anesthesia.

详细描述

Patients in the intervention group will receive lemborexant, while those in the control group will receive a matching placebo. The primary outcome is the incidence of POD within 5 days after surgery. Secondary outcomes include sleep quality on postoperative days 1, 3, and 5, delirium severity and subtype, hospital anxiety and depression scores, quality of emergence from anesthesia, adverse events, and hematological parameters. The expected findings will provide evidence on the safety and efficacy of prophylactic perioperative lemborexant in improving postoperative outcomes in older patients, and will offer a theoretical and practical foundation for future research and clinical application.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
60 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age ≥60 years old;
  • ASA classification I to III;
  • Patients undergoing elective surgery;
  • Sign the informed consent form.

排除标准

  • Tracheal intubation is expected to be retained after the operation;
  • Previous history of alcohol or drug abuse;
  • Severe abnormalities in liver and kidney functions;
  • Long-term use of sedative-hypnotic drugs;
  • Severe sleep apnea and COPD;
  • Inability to cooperate in mental state;
  • Craniocerebral surgery
  • Pregnant and lactating patients;
  • Use drugs that affect orexin metabolism.

研究组 & 干预措施

The intervention group

Experimental

干预措施: Lemborexant Pill (Drug)

The control group

Placebo Comparator

干预措施: Placebo tablet (Drug)

结局指标

主要结局

The incidence of POD

时间窗: The 1st to 5th day after the operation

The incidence of POD within 5 days after surgery

次要结局

  • Postoperative sleep quality(On the 1st, 3rd and 5th days after the operation)
  • Postoperative sleep quality(The Richards-Campbell Sleep Questionnaire)(On the 1st, 3rd and 5th days after the operation)

研究者

发起方
Beijing Tiantan Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

Ruquan Han

Principal Investigator

Beijing Tiantan Hospital

相似试验